RNS Number : 7492T Renalytix PLC 21 March 2023   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered

RNS Number : 5994T Renalytix PLC 21 March 2023     Renalytix plc    ("Renalytix" or the "Company")   Update on FDA De Novo Marketing Authorization Process   LONDON and SALT LAKE CITY , March 21, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the review process with the Food and

RNS Number : 6575S Renalytix PLC 13 March 2023   Renalytix plc    ("Renalytix" or the "Company")   Statement re. Silicon Valley Bank   LONDON and SALT LAKE CITY , March 13, 2023   --  Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) is aware of media reports indicating the closure of Silicon Valley Bank

RNS Number : 0458S Renalytix PLC 07 March 2023     Issue of Shares   LONDON and SALT LAKE CITY , March 7, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company's Employee Share Purchase Plan (the "ESPP"), 166,674 new ordinary shares of £0.0025 each in the capital of the

RNS Number : 6255P Renalytix PLC 10 February 2023     TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)   i 1a. Identity of the issuer or the underlying issuer of

RNS Number : 6203P Renalytix PLC 10 February 2023   Renalytix plc    ("Renalytix" or the "Company")   Director/PDMR Dealing   LONDON and SALT LAKE CITY , February 10, 2023   --  Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) confirms that further to the announcement on February 8 of a c.

LONDON and SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah.

RNS Number : 3776P Renalytix PLC 09 February 2023     Renalytix to Participate in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference   LONDON and SALT LAKE CITY , February 9, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW.

RNS Number : 2418P Renalytix PLC 08 February 2023   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ,  CANADA ,  AUSTRALIA , JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES